Back

Progressive fibrosis burden and primary prevention ICD decision in hypertrophic cardiomyopathy: a genetics- and imaging-based case

10 May 2026 (10:30 - 10:41)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy across time: early clues, evolving phenotypes, and risk Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Omer Gok

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkiye)

3 More presentations in this session

Presentation thumbnail
Obstruction-driven HFpEF in hypertrophic cardiomyopathy: a multimodal, guideline-based approach
Doctor F. Giru (Timisoara, RO)
Slides Video
Presentation thumbnail
Unmasking hypertrophic cardiomyopathy in women: the challenge of early detection
Doctor M. Barki (Milan, IT)
Slides
Presentation thumbnail
The thinner the better? A journey through the clinical evolution of hypertrophic cardiomyopathy
Doctor A. Parodi (Padova, IT)
Slides

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy across time: early clues, evolving phenotypes, and risk
Video

The Event

Event poster

Heart Failure 2026

10 May 2026 10:30 CET
You may be interested in
thumbnail
Congress Session
Hypertrophic cardiomyopathy across time: early clues, evolving phenotypes, and risk
thumbnail
Congress Session
Hypertrophic cardiomyopathy in practice: case-based decisions in treatment and risk management
thumbnail
Congress Presentation
Arrhythmic risk in hypertrophic cardiomyopathy: when and how to intervene

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources